United States · FDA National Drug Code directory
Depo-SubQ Provera
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0009-4709_641b0fea-8376-4405-aea2-ac972c4a65eb
- Product NDC
- 0009-4709
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- medroxyprogesterone acetate
- Labeler
- Pharmacia & Upjohn Company LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20050502
- Source listing expiry
- 20261231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 104 mg/.65mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0009-4709-13) / .65 mL in 1 SYRINGE · 0009-4709-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →